Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ibandronate for steroid-induced osteoporosis in SLE
NCT00668330Phase 4Completed
- Sponsor
- The Chinese University of Hong Kong
- Start
- Apr 2007
- Primary completion
- May 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of ibandronate in osteoporosis, sponsored by The Chinese University of Hong Kong. Primary endpoint: Prevalence of low bone mineral density and vertebral fractures. Started Apr 2007; status: completed.
02
Drugs
ibandronate
03
Conditions
osteoporosis
Beyond the preview
Go deeper on NCT00668330.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00668330.